Viral replication assays.

YT Yuki Takamatsu
MA Manabu Aoki
HB Haydar Bulut
DD Debananda Das
MA Masayuki Amano
VS Venkata Reddy Sheri
LK Ladislau C. Kovari
HH Hironori Hayashi
ND Nicole S. Delino
AG Arun K. Ghosh
HM Hiroaki Mitsuya
request Request a Protocol
ask Ask a question
Favorite

Viral replication assays were performed using recombinant HIV-1 mutants harboring single amino acid substitutions, as previously described (59, 66). In brief, recombinant HIV-1NL4-3-based infectious clones were generated using the QuikChange II XL site-directed mutagenesis kit (Agilent Technologies, Santa Clara, CA) and transfected into HEK293T cells by using Attractene transfection reagent (Qiagen). The viruses were harvested at 72 h after the transfection, and viral p24 antigen was measured using a Lumipulse G1200 instrument. Replication of HIV-1 mutants was determined as described previously (59, 66), with minor modifications. Briefly, MT-4 cells (density, 1.5 × 106 cells in 20 ml RPMI medium) were exposed to the HIV-1 mutants with 20 ng/ml of the p24 antigen and were cultured without the antiretroviral agents for 10 days. Fresh MT-4 cells (1.0 × 106) were added on days 4 and 8. The amount of the p24 antigen was measured every 2 days, and the average value of each data point was determined from two independent assays.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A